Cargando…
High molecular risk variants, severe thrombocytopenia and large unstained cells count affect the outcome in primary myelofibrosis
Apart from the driver mutations, high molecular risk (HMR) variants and other factors have been reported to influence the prognosis of primary myelofibrosis (PMF). The aim of our study was to investigate the impact of laboratory and molecular characteristics at the time of diagnosis (TOD) on the PMF...
Autores principales: | Kanduła, Zuzanna, Janowski, Michał, Więckowska, Barbara, Paczkowska, Edyta, Mroczkowska-Bękarciak, Aleksandra, Sobas, Marta, Lewandowski, Krzysztof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457229/ https://www.ncbi.nlm.nih.gov/pubmed/37507589 http://dx.doi.org/10.1007/s13353-023-00771-x |
Ejemplares similares
-
JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome
por: Kanduła, Zuzanna, et al.
Publicado: (2022) -
BCR::ABL1-negative myeloproliferative neoplasms in the era of next-generation sequencing
por: Mroczkowska-Bękarciak, Aleksandra, et al.
Publicado: (2023) -
Essential thrombocythaemia progression to the fibrotic phase is associated with a decrease in JAK2 and PDL1 levels
por: Lewandowski, Krzysztof, et al.
Publicado: (2022) -
Rapid progression of myelofibrosis in polycythemia vera patient carrying SRSF2 c.284C>A p.(Pro95His) and unique ASXL1 splice site c.1720‐2A>G variant
por: Kanduła, Zuzanna, et al.
Publicado: (2022) -
Primary Immune Thrombocytopenia and Essential Thrombocythemia: So Different and yet Somehow Similar—Cases Series and a Review of the Literature
por: Sobas, Marta, et al.
Publicado: (2021)